Home/Pipeline/FUSE Study (Clinical Evidence Generation)

FUSE Study (Clinical Evidence Generation)

Three-Level Anterior Cervical Discectomy and Fusion with Posterior Stabilization

Post-Market StudyActive

Key Facts

Indication
Three-Level Anterior Cervical Discectomy and Fusion with Posterior Stabilization
Phase
Post-Market Study
Status
Active
Company

About Providence Medical Technology

Providence Medical Technology is a U.S.-based medical device innovator specializing in spinal care, particularly for high-risk cervical and lumbar fusion procedures. The company champions a 'total segmental fusion' philosophy, arguing that anterior fusion alone is insufficient for certain patients, and has developed the CORUS™ platform to provide supplemental posterior stabilization. Its strategy is supported by recent clinical evidence, including a 2025 randomized controlled trial published in SPINE, and focuses on surgeon training and compatibility with robotic navigation. As a private company, it is commercializing its differentiated implant systems and access instruments in the competitive spine surgery market.

View full company profile